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Background: For more than three millennia, rabies has
been one of the most feared human diseases. An early con-
ﬁrmation of rabies is important for timely immunization
and to prevent unnecessary post-exposure prophylaxis. The
conventional viral antigen detection by direct immunoﬂuo-
rescence (DIF) and seller staining are less sensitive and the
gold standard MIT however is laborious and time consuming.
Thus, the present study was carried out i) to compare RT-
PCR result with DIF and seller staining, and ii) to determine
its role in early diagnosis of rabies.
Methods: Skin biopsies and corneal impression smears
were collected ante mortem and brain tissue and CSF
were collected at autopsy, from suspected rabies patients.
Reverse transcriptase polymerase chain reaction (RT-PCR)
was done to detect viral RNA in patients and infected mice
tissues. To determine the earliest appearance of rabies virus
RNA in the mouse tissues, ﬁxed virus and clinical isolates
were inoculated intracerebrally into mice. Two newborn
mice per day were sacriﬁced at two day intervals from day 2
- 8 for ﬁxed virus and day ﬁve till death in clinical isolates.
Mice brain tissue and muzzle skins were subjected to DIF,
Seller and RT-PCR
Results:Of 10 samples, six postmortem brain tissues were
positive by RT-PCR followed by 5 by DIF and 4 for negri bod-
ies. Rabies viral RNA could be detected as early as the 3rd
day of infection by RTPCR in brain as well as muzzle tissues
followed by rabies viral antigen by DIF on day 5th and symp-
toms on day 7 in ﬁxed rabies virus infected mice, where as no
qualitative difference was observed between 3 techniques
when examined 5 days onwards.
Conclusion: The present study thus highlights the impor-
tance of RT-PCR as a more sensitive technique with the
potentiality for early conﬁrmation of rabies as compared to
conventional techniques.
doi:10.1016/j.ijid.2008.05.1334
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Coxsackieviruses (CV) are associated with several clinical
manifestations ranging from mild upper respiratory infec-
tions to meningitis and myocarditis. Different serotypes
have been implicated in the appearance of different mani-
festations. Nowadays, virus identiﬁcation depends on virus
isolation and cultivation and the use of neutralization tests.
In this study, we developed an Enzyme-Linked Immunosor-
bent Assay (ELISA) with the ability to discriminate among
different serotypes of Coxsackie viruses.
Fifteen-mer peptides were synthesized in order to
include the sequences where the antigenic protein VP1 dif-
fers among Coxsackie B3, B4 and A24 serotypes (pepB3,
pepB4 and pepA24, respectively). The peptides were syn-
thesized in conjunction with an oligopeptide carrier (MAP)
and applied in the ELISA assay. In parallel, a commercial
ELISA based on the VP1 protein of Coxsackieviruses B1/B5
as antigen was used. Sera were obtained from 200 healthy
donors and examined for the presence of antibodies against
pepB3, pepB4, pepA24 and VP1-B1/B5.
IgG antibodies against peptides of Coxsackie B3, B4
and A24 were detected at 23%, 33% and 36% of sera
tested, respectively, while IgG antibodies against the VP1 of
Coxsackie B1/B5 were found at 20,5% of the samples. Inhi-
bition experiments demonstrated that (i) pepB3, pepB4 and
pepA24 inhibited their homologous recognition by antibod-
ies in ELISA at 57—87%, (ii) anti-pepA24 possess a distinct
antigenic speciﬁcity, producing a heterologous inhibition
of < 35% in anti-pepB3 and anti-pepB4 assays and (iii) anti-
pepB3 and anti-pepB4 are distinct but their activities are
related (demonstrating a heterologous inhibition of 8—68%,
depending on serum, r = 0,49, p < 0,0001). Urea dissociation
experiments demonstrated that anti-pepA24 antibodies can
react speciﬁcally with high avidity with their peptide sub-
strate, resisting even to the treatment of 8M urea.
The peptides pepB3, pepB4 and pepA24 can be used
for the detection of antibodies against Coxsackieviruses
enabling the discrimination among different coxsackieviruse
serotypes.
doi:10.1016/j.ijid.2008.05.1322
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Background: Cytomegalovirus (CMV) is an important
pathogen in morbidity and mortality in immunocompromised
patients including AIDS patients, infants, and transplant
patients. In these patients, early detection and monitor-
ing of CMV infection before clinically signiﬁcant disease
occurred may be useful for antiviral therapy and also allow
detection of antiviral drug resistance. Today, nucleic acid
detection assays are generally preferred over culture-based
methods for detection of CMV infection. A real-time PCR
assay based on highly conserved CMV glycoprotein B (gB) was
developed to quantify the cytomegalovirus genome load.
Methods: CMV glycoprotein B containing plasmid was
constructed by using the TOPO TA cloning procedures with
plasmid pCRR2.1 (Invitrogen, Carlsbad, Calif.). The standard
curve was established by plotting the CMV plasmid DNA input
against the corresponding threshold cycle (Ct) values. Taq-
Man polymerase chain reaction assays based on CMV gB was
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developed for quantifying CMV DNA in immunocompromised
patients
Results: The detection limit of TaqMan polymerase chain
reaction assay for CMV-DNA was 10 genome per reaction and
the linear measure interval was 1 to 107 copies per reac-
tion (r2 = 0.999). The reproducibility of the TaqMan assay
was initially evaluated by interassay (between-runs) and
intraassay (within-run). The interassay and intraassay coefﬁ-
cients of variation were 9.79% and 10.85%, respectively. The
speciﬁcity of the assay was determined among herpesviridae
subfamily. No positive signals were detected. Initial appli-
cation of the quantitative real-time PCR to serum of infant
indicated the effective of assay for CMV quantitation with
100% sensitivity (n = 5).
Conclusion: In-house TaqMan assays may potentially serve
as a useful tool for rapid quantiﬁcation of CMV infections in
immunocompromised patients.
doi:10.1016/j.ijid.2008.05.1323
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Isolation of inﬂuenza A virus by tissue culture is the
traditional gold standard for laboratory detection and is
important for tracking antigenic changes of the virus. How-
ever, viral isolation is not useful for rapid clinical diagnosis
of infection and is not practical for large-scale epidemi-
ological studies. The application of molecular diagnostics
overcomes these limitations and increases the detection
rate of inﬂuenza virus by 3 - 60%. Although optimal param-
eters for specimen storage to support subsequent virus
isolation have been determined, these parameters have not
been deﬁned for nucleic acid testing. In order to deﬁne these
parameters, we evaluated the ability to detect inﬂuenza
A virus by molecular assays under different storage condi-
tions, including temperature, storage medium, and time.
We analyzed samples kept in different storage temperatures
(4 ◦C, −20 ◦C, −70 ◦C), storage time (1, 7, 14 and 28 days)
and different storage medium (viral transport medium or
ethanol). These conditions were evaluated for both swabs
and extracted RNA samples. The Luminex multiplex bead-
based assay was used for molecular detection of inﬂuenza
A virus matrix gene and hemagluttinin subytping. Although
we were able to detect inﬂuenza A virus in all storage
conditions, there was a 25—42% decrease in the mean ﬂuo-
rescent intensity (MFI) signal over time for both matrix and
hemaglutinnin for swabs stored in VTM at 4 ◦C. Loss of MFI
signal by swabs stored in VTM was minized by storage at
either −20 ◦C or −70 ◦C. We did not observe a loss of MFI
signal in swabs stored in ethanol at either 4 ◦C or −20 ◦C,
although a slight decrease in MFI signal was observed in
samples stored at −70 ◦C.(This really needs to be repeated,
does not agree with other results). Results of our study
suggest that ethanol storage of specimen may provide an
optimal transport medium for samples collected at remote
sites where maintenance cold-chain requirements may be
difﬁcult. Results from other respiratory viruses will also be
presented.
doi:10.1016/j.ijid.2008.05.1324
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Background: this study was carried out to assess the
diagnostic and prognostic value of cytomegalovirus (CMV)
determination in whole blood (heart and intestinal recip-
ients) and in biopsy tissue samples (intestinal recipients)
from transplant patients during virological surveillance and
analyse the CMV T cell response after transplantation.
Methods: we monitored 30 heart transplant recip-
ients (HTR) comprising three R-/D+ and 34 intestinal/
multivisceral transplant (SBMTR) comprising three R-/D+ by
CMV pp65 antigenemia and Real Time PCR . Immunological
surveillance was done in 12 HTR and 9 SBMTR. T lymphocyte
suspensions obtained using a Ficoll gradient were processed
by ELISPOT, an immunoenzyme assay based on the search
for T cells with viral speciﬁc antigens of one of the pro-
tein markers of cell activation (IFN-gamma). Around 2000
blood samples and 1200 intestinal biopsy specimens were
processed for virological tests and 56 were analysed by
ELISPOT
Results: 70% (21/30) and 44% (15/34) of HTR and SBMTR
developed active CMV infection, respectively. Of the 21 HTR
infected four had a mild-moderate symptomatic infection
(leucopenia and fever). Of the 15 SBMTR infected patients
two had a severe symptomatic CMV infection (pneumonia,
enteritis and rejection) which led to the patient’s death and
three had a mild infection (fever).
Conclusion: quantitative determination of CMV in blood
and organ biopsy by molecular tests is the elective assay for
monitoring viral load, since it directly correlates with viral
replication and clinical symptoms. The preliminary outcome
of immunological monitoring shows i) a CMV T-cell immune
response in the ﬁrst month after transplantation was asso-
ciated with a reduction in mean and peak CMV viral load
and; ii) a good and early reconstitution or development of
the CMV-speciﬁc T-cell response can shorten the duration of
CMV infection and control the risk to incur repeated episodes
linked to a recurrent infection.
doi:10.1016/j.ijid.2008.05.1325
